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Abstract
Purpose: This study evaluates the performance of several parametric methods for assessing
[11C]flumazenil binding distribution in the rat brain.
Procedures: Dynamic (60 min) positron emission tomography data with metabolite-corrected
plasma input function were retrospectively analyzed (male Wistar rats, n = 10). Distribution
volume (VT) images were generated from basis function method (BFM), Logan graphical
analysis (Logan), and spectral analysis (SA). Using the pons as pseudo-reference tissue,
binding potential (BPND and DVR–1) images were obtained from receptor parametric
imaging algorithms (RPM and SRTM2) and reference Logan (RLogan). Standardized
uptake value images (SUV and SUVR) were also computed for different intervals post-
injection. Next, regional averages were extracted from the parametric images, using pre-
defined volumes of interest, which were also applied to the regional time-activity curves
from the dynamic data. Parametric data were compared to their regional counterparts and
to two-tissue compartment model (2TCM)-based values (previously defined as the model of
choice for rats). Parameter agreement was assessed by linear regression analysis and
Bland-Altman plots.
Results: All parametric methods strongly correlated to their regional counterparts (R2 9 0.97) and
to the 2TCM values (R2 ≥ 0.95). SA and RLogan underestimated VT and BPND (slope of 0.93
and 0.86, respectively), while SUVR-1 overestimated BPND (slope higher than 1.07 for all
intervals). While BFM and SRTM2 had the smallest bias to 2TCM values (0.05 for both), ratio
Bland-Altman plots showed Logan and RLogan displayed relative errors which were comparable
between different regions, in contrast with the other methods. Although SUV consistently
underestimated VT, the bias in this method was also constant across regions.
Conclusions: All parametric methods performed well for the analysis of [11C]flumazenil
distribution and binding in the rat brain. However, Logan and RLogan slightly outperformed
the other methods in terms of precision, providing robust parameter estimation and
constant bias. Yet, other methods can be of interest, because they can provide tissue
perfusion (i.e., K1 with BFM and SA), relative flow (i.e., R1 with RPM and SRTM2), and
model order (SA) images.
Correspondence to: Ronald Boellaard; e-mail: r.boellaard@umcg.nl
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Introduction
The in vivo study of neuronal integrity has been well
established by means of positron emission tomography
(PET) imaging with [11C]flumazenil [1, 2]. A number of
different conditions have previously been studied with
[11C]flumazenil [3–5], and the link between the GABA-
ergic system and neurological disorders [6] and inflamma-
tion [7] has increased the applicability and interest in PET
imaging with this radiotracer.
In addition to the non-invasive character of PET, one of
its main advantages for studying physiological processes is
that it can provide quantitative information. Full quantitative
analysis can be achieved by pharmacokinetic modeling,
which describes the time course of the PET tracer in tissue
and enables the estimation of different parameters related to
tracer distribution, metabolism, or receptor density and
binding [8, 9]. In that context, the quantification of
[11C]flumazenil binding has been previously performed by
different pharmacokinetic models. In human studies, the
one-tissue compartment model (1TCM) and the simplified
reference tissue model (SRTM) [10] using the pons as a
reference tissue have been validated [11] and applied [12–
14]. Although useful, these models have been mostly
applied for regional quantification of [11C]flumazenil bind-
ing, analyzing the average kinetic profile of a specific
volume of interest (VOI).
In cases when subtle or disease-specific changes are
expected, VOI-based pharmacokinetic modeling might be
suboptimal precisely due to the use of pre-defined VOIs. If
physiological changes are restricted to a subset of a region
(tissue heterogeneity) or if they do not follow anatomical
delineations, the average signal from pre-defined VOIs
might not be able to properly describe the underlying
alterations. There, the generation and analysis of paramet-
ric images can be of greater use. Parametric images are
graphical representations of quantitative endpoints, where
every image voxel corresponds to a kinetic parameter, such
as distribution volume (VT) or binding potential (BPND).
Although parametric imaging is most commonly applied to
human studies, it could be of great interest for the analysis
of animal PET data. Preclinical PET imaging plays an
important role in drug development and treatment assess-
ment studies, for example, and it could be advantageous to
explore full kinetic analysis of subtle physiological
changes by parametric imaging also in the context of such
animal study designs. Moreover, parametric imaging
enables group comparisons at the voxel level using
statistical parametric mapping (SPM), which performs the
statistical analysis independent of pre-defined regions of
interest.
In human studies, parametric images of [11C]flumazenil
binding have been generated from a number of different
methods, and the Logan graphical analysis, a multilinear
reference tissue model (MRTM2), and the receptor parametric
mapping method (RPM) were found to provide the best
quantitative metrics [15]. However, no similar analysis has
been performed for animal data. Moreover, the preference and
performance of VOI-based models have already been shown to
differ between human and rat studies [16]. Together with the
higher noise levels typical of animal PET data, this difference
could indicate the parametric models found to work best for the
analysis of human studies might not be the most appropriate in
the pre-clinical setting.
The aim of the current study was, therefore, to investigate
the performance of several parametric methods for the
analysis of [11C]flumazenil PET images of the rat brain.
To that end, we retrospectively analyzed [11C]flumazenil
pre-clinical images with both plasma input and reference
tissue-based parametric methods and compared the results to
their corresponding VOI-based pharmacokinetic models.
Material and Methods
Animal Data
We retrospectively analyzed male Wistar-Unilever outbred
rats (n = 10) obtained from Harlan (Horst, The Netherlands).
The animal experiments were performed according to the
Dutch Law on Animal Experiments and were approved by
the Institutional Animal Care and Use Committee of the
University of Groningen (6264B).
Data Acquisition
Prior to the PET scan, a mixture of 5 % isoflurane and medical
air was used to anesthetize the animals, which were maintained
under anesthesia at 1.5–2.0 %, with a flow of 1.5–2 ml/min.
Scans were performed in the Focus 220 camera (Siemens
Medical Solutions, USA), where animals were positioned
transaxially with the head in the field of view. First, a
transmission scan was performed with a point-source of Co-
57. Next, [11C]flumazenil was injected (bolus injection) with
an automatic pump over 60s, and the PET camera was started at
the moment of injection. List-mode PET data was acquired for
a period of 60 min. [11C]Flumazenil was synthesized as
previously described [17], and a 53 ± 18 % radiochemical
yield was obtained, with radiochemical purity of
[11C]flumazenil of 100 % and a pH of 6.5–7. The mean
injected activity was 59.3 ± 22.6MBq, with a 3.3 ± 2.4 nmol of
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injected mass, and the weight of the animals was
0.273 ± 0.03 kg [18].
During the scan, arterial blood samples (0.1 ml) were
obtained (n = 16) for each individual animal, correspond-
ing to 5, 10, 15, 30, 45, and 60 min post-injection (p.i.).
The samples were subsequently separated into blood and
plasma, and the activity was measured in a gamma
counter (LKB-Wallac, Finland). For the metabolite analy-
sis, 2–3 larger samples (0.6 ml) were collected for each
animal, and a population metabolite curve was constructed
by combining data from the individual samples. The
validity of using a population-based metabolite curve in
this animal group was previously assessed and reported
elsewhere [17, 18]. Finally, this curve was used for the
construction of individual metabolite-corrected plasma
input functions.
Image Processing
After all necessary corrections, the list-mode data was
reconstructed into 21 frames (6 × 10, 4 × 30, 2 × 60, 1 × 120,
1 × 180, 4 × 300, and 3 × 600 s). The 2D–OSEM algorithmwas
used to reconstruct the Fourier rebinned sinograms, with 4
iterations and 16 subsets. The resulting images displayed a
128 × 128 × 95 matrix, 0.63 mm pixel width, and 0.79 mm
slice thickness. Next, individual dynamic images were
coregistered to a [11C]flumazenil template [19] in PMOD
v3.7 (PMOD Technologies Ltd., Switzerland). Time-activity
curves (TACs) were then generated from a set of pre-defined
bilateral VOIs which included the whole brain, regions with
high GABAA expression (frontal cortex and hippocampus),
and regions with low GABAA expression (cerebellum,
medulla, and pons). Following previous studies [16], the pons
was set as the pseudo-reference tissue and its TAC was used as
input for reference-based models. In order to minimize bias
induced by noise in the parametric methods, an isotropic 3D
Gaussian filter (FWHM = 0.8 mm) was applied. Finally,
individually generated brain masks were also applied prior to
modeling.
Pharmacokinetic Modeling
All pharmacokinetic modeling was performed with the
PPET [20] software package.
First, parametric VT images were generated from three
different methods, including the basis function method
(BFM), which is an implementation of the 1TCM, the
Logan graphical analysis (Logan) [21], and the spectral
analysis (SA) [22]. For these methods, the metabolite-
corrected plasma curve was used as input function, and
blood volume fraction was accounted for as a fit parameter
in BFM and SA. Next, parametric BPND images were
computed from three reference-based models. The first was
the reference tissue Logan graphical analysis (RLogan) [23],
which provides the distribution volume ratio (DVR) of target
regions relative to the reference tissue. Following the
relationship BPND = DVR−1 [8], we subtracted 1 from the
RLogan DVR to allow direct comparison to parametric
images of BPND. The other two methods consisted of two
implementations of the receptor parametric mapping method
(RPM and SRTM2) [24], which correspond to the two
versions of the simplified reference tissue model (SRTM and
SRTM2). For the SRTM2, the model fit was performed in
two steps, where the median value of the reference tissue
efflux rate constant (k ′2) obtained from all voxels outside the
reference tissue in the first run was entered as a fixed
parameter for the second run [25]. An overview of the
settings used for the parametric methods and optimized for
this group can be found in Table 1.
Parametric images of standardized uptake value (SUV)
and SUV target to pons ratio (SUVR) were also
generated for the intervals 30–40 min, 40–50 min, and
50–60 min post-injection and subsequently referred to by
SUVstart-end and SUVRstart-end. In order to compare SUVR
and BPND images, 1 was subtracted from the derived
SUVR values, assuming equilibrium was reached for
those intervals.
Method Evaluation
Results from each of the parametric methods were compared
to (1) the corresponding regional (VOI) analysis using
equivalent kinetic models but also to (2) reference values
based on regional two-tissue compartment model (2TCM)
fits. The 2TCM-derived parameters (VT and DVR−1) were
considered as reference values for method comparison. An
overview of parametric methods, their corresponding VOI-
models, parameter of interest, and equivalent 2TCM param-
eter can be found in Table 2.
For that purpose, first the same pre-defined set of VOIs
used for the generation of TACs were projected onto the
parametric images, and average parameter estimates were
obtained for each region. Next, the regional TACs were
analyzed by six models corresponding to the parametric
methods (i.e., 1TCM, Logan, SA, RLogan, SRTM, and
SRTM2) and by the 2TCM. In the plasma input models,
blood- and metabolite-corrected plasma curves were used as
input function, with a fixed blood volume of 5 %. Finally,
the regionally averaged values from parametric methods
were compared to both their VOI-counterparts and to the
corresponding 2TCM-derived reference.
Statistical Analysis
Parameter agreement was assessed by linear regression
analysis and Bland-Altman plots. Results were consid-
ered significant when p G 0.05 and are expressed as
mean ± SD.
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Results
Volume of Distribution
Visual inspection of parametric VT images showed good
correspondence between methods and the expected
[11C]flumazenil distribution in the rat brain (Fig. 1).
Compared to their VOI-counterpart, parametric Logan was
the method with the best correlation, displaying an R2 = 0.99
and a slope of 0.97 when the regression line was set through the
origin (Table 3). The BFM also strongly correlated to its
counterpart (1TCM) values (R2 = 0.98), with a slope of 1.03.
The slope of the linear regression of SA with its counterpart
was further from identity (0.89), and the correlation was
somewhat lower than the other methods (R2 = 0.96). Overall,
all three methods showed excellent correlation (R2 = 0.99) to
2TCM reference VT values (Fig. 2a). However, BFM was the
method which displayed the slope closest to the identity line
(0.98). Although SA showed the same correlation coefficient as
the other two methods, a slope of 0.93 indicated a larger
underestimation in VT values.
The Bland-Altman analysis showed that, despite the good
correlation, a negative bias (−0.20) was present with the
Logan method (Fig. 2b). The BFM had the smallest overall
bias in relation to 2TCM VT (0.05), yet its 95 % limits of
agreement were slightly wider than those of Logan
(Table 4). SA had the widest 95 % limits of agreement
similar to BFM and an overall higher (negative) bias
(−0.49). Figure 2c shows a ratio Bland-Altman plot to
highlight the performance in parameter agreement for the
different levels of VT values. There, regions with high VT
(≥6) had a ratio close to one in comparison with 2TCM VT
values. On the other hand, larger over- and underestimations
occurred for regions of lower VT (G6).
Figure 3 displays the range of differences to 2TCM
values for the three parametric methods across all regions.
Significant differences in bias were found in all three
methods when compared to 2TCM values. However, the
bias from parametric Logan compared to 2TCM values
showed the smallest variability (SD = 0.19), indicating
higher precision for this method compared to the others.
Binding Potential (BPND and DVR−1)
As can be seen in Fig. 1, the highest [11C]flumazenil binding
spatially matched regions with a high receptor density
(cortical and sub-cortical areas), while the lowest was seen
in low-density ones (cerebellum and brainstem). Images of
receptor binding were also visually comparable between
parametric methods.
All reference-based methods performed well in comparison
to 2TCM DVR−1 (Fig. 4a). In particular, DVR–1 from
RLogan displayed the best correlation coefficient in relation
to 2TCM values (R2 = 0.99), while the slope was the furthest
from the identity line (0.86), indicating underestimation of
receptor binding. Binding estimates from RPM showed
correlation to 2TCM values similar to those of RLogan
(R2 = 0.98) and a slope closer to identity (0.93) (Table 3).
Estimation of binding from parametric SRTM2 outperformed
both other methods in terms of linear regression, with a R2 of
0.98 and a slope of 0.98 compared to 2TCM values.
Bland-Altman plots indicated a similar performance
between RLogan and RPM methods (Fig. 4b). Both
parametric methods displayed a negative bias compared to
2TCM DVR–1 (−0.17 for RLogan and −0.10 for RPM).
Table 1. Overview of settings for parametric methods
Method Start t (min) End t (min) Basis start t (min) Basis end t (min) # basis functions
VT (K1) BFM – – 0.00083 0.016 50
Logan 10 60 – –
SA – – 0.00333 0.333 30
SUV SUV30–40 30 40 – –
SUV40–50 40 50 – –
SUV50–60 50 60 – –
BPND (R1) RLogan 10 60 – –
RPM – – 0.01 0.2 50
SRTM2 – – 0.01 0.2 50
SUVR30–40–1 30 40 – –
SUVR40–50–1 40 50 – –
SUVR50–60–1 50 60 – –








1TCM BFM VT – 2TCM VT
Logan Logan VT – 2TCM VT
SA SA VT K1 and model
order
2TCM VT
– SUV SUV – 2TCM VT
RLogan RLogan DVR – 2TCM
DVR–1
SRTM RPM BPND R1 2TCM
DVR–1
SRTM2 SRTM2 BPND R1 2TCM
DVR–1
– SUVR SUVR – 2TCM
DVR–1
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SRTM2 showed a small overall bias (0.05) but resulted in
the largest 95 % limits of agreement to 2TCM DVR–1, as
can be seen in Table 4. For most levels of specific binding,
all three methods showed good relative agreement, with a
ratio close to one in comparison with 2TCM DVR–1 values
(Fig. 4c). However, relative errors were larger for BPND
values close to zero.
In Fig. 3, a similar performance between the reference
methods can be seen. Significant differences were found in
the bias of parametric RLogan and SRTM2 when compared
to 2TCM values. No significant difference was seen for the
RPM bias to 2TCM values (p = 0.20). Yet, RLogan
displayed the highest precision (SD = 0.72) compared to
the other two methods.
Fig. 1 Representative (n = 1) parametric images of aVT, b SUV30–40, cBPND, dK1 images, and eR1 images.
Table 3. Linear regression analysis between parametric methods and their VOI-counterparts, as well as between parametric and reference values from 2TCM
(VOI). Linear regression analysis was performed with and without setting the intercept to zero (through origin columns)
Model VOI-counterpart VOI-2TCM
R2 Slope Int. R2 Slope R2 Slope Int. R2 Slope
(Through origin) (Through origin)
Distribution volume
BFM 0.96 0.79 1.35 0.98 1.03 0.96 0.85 0.78 0.99 0.98
Logan 0.99 1.03 −0.35 0.99 0.97 0.98 0.98 −0.13 0.99 0.96
SA 0.85 0.94 −0.28 0.96 0.89 0.98 1.08 −0.87 0.99 0.93
SUV30–40 – – – – – 0.87 0.27 −0.16 0.96 0.24
SUV40–50 – – – – – 0.87 0.21 −0.15 0.96 0.18
SUV50–60 – – – – – 0.83 0.16 −0.09 0.95 0.14
Binding potential
RLogan 0.99 1.03 −0.10 0.99 0.97 0.98 0.92 −0.10 0.99 0.86
RPM 0.98 1.15 −0.09 0.99 1.08 0.97 0.98 −0.82 0.98 0.93
SRTM2 0.95 1.32 −0.63 0.97 0.91 0.97 0.89 0.15 0.98 0.98
SUVR30–40–1 – – – – – 0.98 1.21 −0.14 0.99 1.13
SUVR40–50–1 – – – – – 0.97 1.30 −0.16 0.98 1.21
SUVR50–60–1 – – – – – 0.94 1.17 −0.17 0.96 1.07
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SUV and SUVR–1
Correlation between parametric SUV and 2TCM VT was
overall strong, with similar correlation coefficients across
intervals p.i. (R2 = 0.96, R2 = 0.96, and R2 = 0.95 for
SUV30–40, SUV40–50, and SUV50–60, respectively). However,
there was a clear scale difference between the two
parameters, and a direct comparison was not possible, as
SUV ranged from 0.2 to 2.7 and 2TCM VT ranged from 1.9
to 9.9 (Fig. 5a). However, ratio Bland-Altman plots showed
that SUV from all three intervals underestimated 2TCM VT
in a similar manner across regions, independent of the levels
of uptake (Fig. 5b).
SUVR–1 images showed excellent correlation to binding
estimates from 2TCM for all intervals p.i. (Fig. 6a).
However, an overestimation of binding potential from
SUVR–1 images was seen, with linear regression (through
origin) slopes of 1.13, 1.21, and 1.07 for the SUVR30–40–1,
SUVR40–50–1, and SUVR50–60–1, respectively. This was
confirmed by a Bland-Altman analysis, where SUVR40–50–1
showed the highest bias compared to 2TCM DVR–1 and the
largest 95 % limits of agreement (Table 4). In a ratio Bland-
Altman, all intervals show similar performance, with the
ratio close to one for most levels of specific binding
(Fig. 6b). For binding values close to zero, relative errors
were more pronounced, independent of the SUVR interval.
Parametric Images of K1, R1, and Model Order
For BFM and SA, parametric images of K1 (influx rate
constant) were also available (Fig. 1). Although both
displayed similar perfusion, BFM K1 was generally higher,
while the less homogeneous distribution seen in the SA
image suggested higher noise sensitivity for that method. SA
also provided parametric images of model order, displaying
the difference in the complexity of kinetic profiles between
different voxels (Fig. 7). In those, a marked difference
between high- and low-density regions is seen, and a more
complex model was more frequently observed in the later,
compared to the former.
Additional parametric images were also available from
RPM and SRTM2 displaying R1, i.e., the ratio between K1 of
a target region and of the pseudo-reference tissue (pons). As
can be seen in Fig. 1, there is a good correspondence
between the two methods. However, R1 images from
SRTM2 displayed better contrast and lower noise levels
compared to RPM R1 images.
Significant (p G 0.01) within-animal correlations were
found between K1 and R1 values of parametric and VOI-
counterparts for all animals when pooling the models
(Spearman’s rho ranged from 0.57 to 0.80). However, when
comparing parametric values to reference 2TCM estimates,
Fig. 2 Regression analysis and Bland-Altman plots of VT compared to 2TCM values. a Linear regression between parametric
(BFM, Logan, and SA) and 2TCM VT values determined by VOI analysis. The solid line is the identity line, and the dashed lines
represent the regression lines. b Bland-Altman plot of the agreement in VT estimation between the parametric methods and the
reference values obtained from the 2TCM (VOI). The dashed line represents zero bias. c Ratio Bland-Altman plot between BFM,
Logan, SA, and 2TCM VT values. The dashed line represents a ratio of one, corresponding to full agreement between methods.
Table 4. Bland-Altman analysis of agreement between parametric and
VOI-counterpart methods, as well as between parametric and 2TCM (VOI)
values
Parameter VOI-counterpart VOI-2TCM
Method Bias 95 % L. A. Bias 95 % L. A.
VT
BFM 0.44 −0.79 to 1.67 0.05 −0.89 to 1.00
Logan −0.20 −0.57 to 0.17 −0.19 −0.74 to 0.34
SA −0.57 −2.42 to 1.27 −0.49 −1.16 to 0.18
BPND
RLogan −0.07 −0.21 to 0.06 −0.17 −0.41 to 0.05
RPM 0.03 −0.28 to 0.34 −0.10 −0.37 to 0.16
SRTM2 −0.22 −0.74 to 0.29 0.05 −0.27 to 0.38
SUVR30–40–1 – – 0.05 −0.37 to 0.49
SUVR40–50–1 – – 0.13 −0.51 to 0.77
SUVR50–60–1 – – −0.01 −0.59 to 0.58
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significant within-animal correlations were found for only 7
out of 10 animals. Moreover, by grouping the animals and
comparing estimates by model, only BFM K1 values were
significantly correlated to VOI-counterpart estimates
(Spearman’s rho 0.68, p G 0.01).
Discussion
The use of parametric imaging methods for the analysis of
PET data can be of importance when subtle and/or disease-
specific changes are expected. In the case of [11C]flumazenil
brain PET, those changes are related to the GABA-ergic
system and can be present in several conditions related to
neuronal loss and inflammatory processes. While parametric
images of [11C]flumazenil distribution and binding have
been generated and applied in human studies, the same has
not yet been done for the pre-clinical setting. Therefore, this
study evaluated several parametric methods for the visual-
ization and analysis of [11C]flumazenil PET images of the
rat brain.
A first analysis of parametric VT images demonstrated
that all three methods tested in this study (BFM, Logan, and
SA) corresponded well to their VOI-counterparts. These
results indicate that the generation of parametric VT maps
from these methods could, to some extent, replicate results
obtained from a regional analysis, which is generally less
Fig. 3 Plot of differences in estimates between 2TCM reference values across regions and a distribution volume and b binding
potential. Individual values are represented by circles, the mean is represented by the black line, and the bars represent the SD.
Fig. 4 Regression analysis and Bland-Altman plots of BPND. a Linear regression between parametric (RLogan, RPM, and
SRTM2) and 2TCM DVR–1 (BPND) values determined by VOI analysis. The solid line represents the identity line, and the dashed
lines correspond to each of the regression lines. b Bland-Altman plot of the agreement in BPND estimation between the
parametric methods and the reference values obtained from the 2TCM (VOI). The dashed line corresponds to zero bias. c Ratio
Bland-Altman plot between BPND of parametric methods and 2TCM BPND. The dashed line corresponds to a ratio of one,
representing full agreement between methods. The y-axis is truncated at −1.0.
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affected by noise and image resolution. More importantly,
there was also an excellent correlation between parametric
values of each of the three parametric methods and VT
estimated from the reference 2TCM VOI analysis. In terms
of parameter agreement, however, a slight difference
between the methods becomes noticeable. While BFM VT
showed a small bias compared to 2TCM values (0.05), the
wide 95 % limits of agreement suggest this method might
not be optimal for parameter estimation at the individual
level. A similar behavior could be seen with VT estimates
from SA. This variability was especially true for regions of
small VT (low-density regions). This observation is in
agreement with a previous report of a VOI analysis, where
we found the difference between 1TCM and 2TCM VT
values to be larger for cerebellum, medulla, and pons [16].
Indeed, model differences seemed to be a function of
receptor density and consequently, a function of the
underlying tissue configuration. As shown in our previous
study [18], a 1TCM configuration leads to major errors in
parameter estimation in low-binding regions, both from
plasma input models and reference models relying on fast
(1 T) kinetics for the reference tissue. On the other hand,
such a range of differences might not be relevant for most
study designs, as regions with low-density of receptors are
Fig. 5 Regression analysis and ratio Bland-Altman plot of SUV from different intervals. a Regression analysis between SUV
(parametric) and 2TCM VT (VOI) for three different intervals p.i. The dashed lines represent the regression lines. b Ratio Bland-
Altman plot between VT estimates from SUV and from 2TCM VT (VOI) for the same intervals.
Fig. 6 Regression analysis and ratio Bland-Altman plot of SUVR from different intervals. a Regression analysis between
SUVR–1 (parametric) and 2TCM BPND (VOI) for three different p.i. intervals. The solid line represents the identity line, and the
dashed lines correspond to each of the regression lines. b Ratio Bland-Altman plot between binding potential estimates from
SUVR–1 and from 2TCM BPND (VOI) for the same intervals. The dashed line corresponds to a ratio of one, representing full
agreement between methods. The y-axis is truncated at −1.0.
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generally not the main focus of an analysis. Nonetheless,
even though this region-dependent range of agreement was
seen in all three methods, the range of differences to 2TCM
values was smallest for Logan, which does not assume a
specific compartmental configuration (Fig. 3). As a conse-
quence, despite the significant bias compared to reference
values, Logan can be considered the most robust of the three
methods for the generation of parametric VT images,
showing a higher precision independent of receptor density
levels. Yet, it is important to note that while VOI analyses
were performed with a fixed blood volume of 5 %,
parametric methods either used it as a fit parameter or freely
incorporated its contribution into the model. Although a
limitation, previous work has shown that different contribu-
tions of blood to the overall signal did not significantly
affect the main outcome parameter [18].
Parametric images of receptor binding were also compara-
ble between different parametric methods. Moreover, a good
correspondence to VOI-counterparts was seen for all reference
methods, with high R2 values and only small over- and
underestimations seen for RPM and SRTM2, respectively
(Table 3). In comparison with reference 2TCM values,
correlation remained high for all methods, and linear regression
slopes were closer to the identity line for the SRTM2.
However, RLogan consistently underestimated binding, with
a regression slope of 0.86. Interestingly, while RPM and
SRTM2 had overall bias similar to those of RLogan (−0.10,
0.05, and −0.17, respectively), the range of differences to
2TCM values was larger for those methods (Fig. 3). In fact, the
differences seen between SRTM2 and 2TCM estimates
reached 0.5 for regions of low-binding—values higher than
the actual BPND estimates—translating into relative errors of
more than 100 % (Fig. 4b, c). However, those correspond to
BPND values close to zero, where large relative errors are not
surprising, nor meaningful. On the other hand, it is also
important to notice that all reference-based methods underes-
timate the true BPND from the start, due to the considerable
levels of specific binding present in the rat pons [16].
Nonetheless, RLogan displayed the highest precision in
estimating receptor binding, as can be seen in Fig. 3. Therefore,
despite its bias to 2TCM values, RLogan can be considered the
most robust reference-based parametric method for the
generation of receptor binding images.
While VT and BPND are important kinetic parameters,
both require dynamic scanning for their estimation. As a
consequence, SUV and SUVR determined from static late
images are widely applied for both regional and parametric
analyses. While SUV does not necessarily correspond to VT,
both parameters are directly related. This was also seen in
our findings, where good correlation (R2 9 0.95) was found
between parametric SUV determined at three p.i. intervals
and 2TCM VT (Fig. 5a). In turn, SUVR is closely related to
BPND, and when equilibrium is reached, SUVR–1 is
expected to correspond to DVR–1. Therefore, a more direct
comparison between SUVR–1 from different intervals p.i.
and BPND could be performed. However, as can be seen in
Fig. 1, this method overestimated BPND from other methods
and DVR–1 from 2TCM (Table 3). The largest overestima-
tion of 2TCM DVR–1 was seen for SUVR40–50 and the
smallest for SUVR50–60, which might indicate equilibrium is
not reached at earlier intervals. Nonetheless, all SUVR–1
strongly correlated to 2TCM DVR–1. It is important to
notice that despite the high correlations, the performance of
SUV and SUVR–1 was region-dependent (Figs. 5a and 6a,
respectively). However, when assessing agreement by a ratio
Bland-Altman, the results suggested a scaling effect for
SUV, since relative errors were similar across regions
(Fig. 5b). Although useful, SUV and SUVR images must
be applied carefully in group comparisons, interventional
and longitudinal studies, since they are especially affected
by changes in metabolism and tissue perfusion [26].
The results of this study indicate that parametric analysis
of [11C]flumazenil images of the rat brain can be satisfac-
torily performed, and, as a consequence, parametric imaging
and SPM analysis would allow direct statistical comparison
across groups and/or conditions without prior assumptions
on regions of interest. In fact, SPM analysis has previously
been able to detect more subtle disease-related changes in an
animal model of inflammation imaged with [11C]PK11195,
for example [27]. However, the homogeneous dataset
analyzed in this study did not allow for a similar assessment
of the performance of parametric imaging in group compar-
ison nor was this within the scope of the study. Thus, further
studies should be performed in order to evaluate the benefit
of parametric imaging of [11C]flumazenil binding in the rat
brain for different conditions and study designs. In general,
Fig. 7 Representative image (n = 1) of model order obtained
from the parametric SA method, displaying, in the different
views, a difference between cortical and non-cortical regions.
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since Logan and RLogan outperformed other methods in
precision and are of robust and simple implementation, both
methods are preferred for group comparisons and longitudi-
nal studies. On the other hand, alternatives such as BFM or
RPM can be of value in generating parametric images with
additional information (K1 or R1), while SUV and SUVR
images could be useful when dynamic scanning is not
possible, despite under- and overestimation of kinetic
parameters.
Conclusion
This study demonstrated several parametric methods per-
formed well for the generation of [11C]flumazenil distribu-
tion and binding images, with a good correlation to 2TCM-
derived values being observed across all methods. Therefore,
a specific method should be applied according to what
information is of interest to a specific research question.
Nonetheless, the most precise and straightforward methods
were found to be Logan and RLogan, while BFM or RPM
could be considered when information on perfusion is of
significance.
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